Go Pro

Hyperfine (HYPR) Financials

Hyperfine logo
$1.02 -0.02 (-1.92%)
Closing price 07/15/2026 04:00 PM Eastern
Extended Trading
$1.02 +0.00 (+0.39%)
As of 07/15/2026 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Hyperfine

Annual Income Statements for Hyperfine

This table shows Hyperfine's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-23 -65 -73 -44 -41 -36
Consolidated Net Income / (Loss)
-23 -65 -73 -44 -41 -36
Net Income / (Loss) Continuing Operations
-23 -65 -73 -44 -41 -36
Total Pre-Tax Income
-23 -65 -73 -44 -41 -36
Total Operating Income
-23 -65 -74 -48 -43 -37
Total Gross Profit
-0.48 -1.17 0.91 4.76 5.89 6.75
Total Revenue
0.29 1.50 6.81 11 13 14
Operating Revenue
0.29 1.50 6.81 11 13 14
Total Cost of Revenue
0.77 2.66 5.91 6.28 7.00 6.81
Operating Cost of Revenue
0.77 2.66 5.91 6.28 7.00 6.81
Total Operating Expenses
23 64 75 53 49 44
Selling, General & Admin Expense
5.92 27 32 20 17 16
Marketing Expense
2.50 10 14 10 9.12 10
Research & Development Expense
15 26 28 22 22 17
Total Other Income / (Expense), net
0.06 0.02 0.71 3.88 2.50 1.51
Interest & Investment Income
0.07 0.02 0.76 3.84 2.49 1.02
Other Income / (Expense), net
-0.01 -0.00 -0.05 0.04 0.01 0.49
Income Tax Expense
0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share
($15.38) ($17.57) ($1.04) ($0.62) ($0.56) ($0.43)
Weighted Average Basic Shares Outstanding
1.52M 3.69M 70.45M 71.32M 72.41M 81.80M
Diluted Earnings per Share
($15.38) ($17.57) ($1.04) ($0.62) ($0.56) ($0.43)
Weighted Average Diluted Shares Outstanding
1.52M 3.69M 70.45M 71.32M 72.41M 81.80M
Weighted Average Basic & Diluted Shares Outstanding
1.52M 3.69M 71.05M 71.95M 77.83M 97.96M

Quarterly Income Statements for Hyperfine

This table shows Hyperfine's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-11 -11 -9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62
Consolidated Net Income / (Loss)
-11 -11 -9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62
Net Income / (Loss) Continuing Operations
-11 -11 -9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62
Total Pre-Tax Income
-11 -11 -9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62
Total Operating Income
-12 -12 -11 -11 -11 -11 -11 -9.60 -8.92 -7.67 -8.56
Total Gross Profit
1.12 1.03 1.35 1.80 1.91 0.83 0.88 1.33 1.85 2.69 1.98
Total Revenue
2.33 2.69 3.30 3.63 3.64 2.32 2.14 2.70 3.44 5.29 3.90
Operating Revenue
2.33 2.69 3.30 3.63 3.64 2.32 2.14 2.70 3.44 5.29 3.90
Total Cost of Revenue
1.21 1.65 1.94 1.83 1.74 1.50 1.25 1.37 1.59 2.60 1.92
Operating Cost of Revenue
1.21 1.65 1.94 1.83 1.74 1.50 1.25 1.37 1.59 2.60 1.92
Total Operating Expenses
13 13 12 13 13 12 12 11 11 10 11
Selling, General & Admin Expense
4.62 4.17 4.43 4.42 4.51 4.13 4.21 3.86 4.15 4.03 4.13
Marketing Expense
2.53 2.53 2.00 2.27 2.50 2.35 2.54 2.52 2.57 2.50 2.56
Research & Development Expense
5.74 5.96 5.57 5.96 5.87 5.11 5.04 4.54 4.05 3.83 3.85
Total Other Income / (Expense), net
1.00 0.95 0.80 0.69 0.64 0.38 1.48 0.32 -2.10 1.80 -0.07
Interest Expense
- - - - - - 0.00 - - - 0.08
Interest & Investment Income
1.02 0.92 0.80 0.68 0.59 0.44 0.32 0.24 0.19 0.28 0.25
Other Income / (Expense), net
-0.02 0.02 0.01 0.02 0.05 -0.06 1.17 0.09 -2.29 1.52 -0.24
Income Tax Expense
0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Basic Earnings per Share
($0.15) ($0.15) ($0.14) ($0.14) ($0.14) ($0.14) ($0.12) ($0.12) ($0.14) ($0.05) ($0.09)
Weighted Average Basic Shares Outstanding
71.46M 71.32M 71.93M 72.04M 72.68M 72.41M 75.70M 78.08M 79.03M 81.80M 97.70M
Diluted Earnings per Share
($0.15) ($0.15) ($0.14) ($0.14) ($0.14) ($0.14) ($0.12) ($0.12) ($0.14) ($0.05) ($0.09)
Weighted Average Diluted Shares Outstanding
71.46M 71.32M 71.93M 72.04M 72.68M 72.41M 75.70M 78.08M 79.03M 81.80M 97.70M
Weighted Average Basic & Diluted Shares Outstanding
71.60M 71.95M 72.01M 72.62M 72.95M 77.83M 77.84M 78.58M 97.17M 97.96M 99.27M

Annual Cash Flow Statements for Hyperfine

This table details how cash moves in and out of Hyperfine's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
38 127 -73 -42 -38 -1.63
Net Cash From Operating Activities
-22 -47 -72 -42 -39 -28
Net Cash From Continuing Operating Activities
-22 -47 -72 -42 -39 -28
Net Income / (Loss) Continuing Operations
-23 -65 -73 -44 -41 -36
Consolidated Net Income / (Loss)
-23 -65 -73 -44 -41 -36
Depreciation Expense
0.29 0.73 1.02 1.05 1.01 1.09
Non-Cash Adjustments To Reconcile Net Income
2.19 9.90 8.03 4.14 3.86 3.16
Changes in Operating Assets and Liabilities, net
-0.58 7.04 -8.22 -2.76 -2.91 3.38
Net Cash From Investing Activities
-1.57 -2.71 -0.59 -0.80 -0.38 -1.19
Net Cash From Continuing Investing Activities
-1.57 -2.71 -0.59 -0.80 -0.38 -1.19
Purchase of Property, Plant & Equipment
-1.57 -2.71 -0.59 -0.80 -0.38 -1.19
Net Cash From Financing Activities
61 177 0.01 0.17 1.02 28
Net Cash From Continuing Financing Activities
61 177 0.01 0.17 1.02 28
Issuance of Common Equity
1.00 3.52 - - 0.85 27
Other Financing Activities, net
0.12 143 0.01 0.17 0.17 0.49

Quarterly Cash Flow Statements for Hyperfine

This table details how cash moves in and out of Hyperfine's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-8.95 -10 -13 -9.40 -7.83 -8.31 -4.14 -7.96 -3.55 14 5.24
Net Cash From Operating Activities
-8.72 -9.94 -13 -9.38 -8.52 -8.36 -9.25 -7.91 -5.58 -5.21 -9.01
Net Cash From Continuing Operating Activities
-8.72 -9.94 -13 -9.38 -8.52 -8.36 -9.25 -7.91 -5.58 -5.21 -9.01
Net Income / (Loss) Continuing Operations
-11 -11 -9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62
Consolidated Net Income / (Loss)
-11 -11 -9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62
Depreciation Expense
0.28 0.26 0.26 0.25 0.26 0.23 0.23 0.28 0.30 0.28 0.27
Amortization Expense
- - - - - - 0.00 - - - 0.02
Non-Cash Adjustments To Reconcile Net Income
1.12 0.53 1.76 0.07 1.00 1.03 -0.28 0.55 3.50 -0.61 0.16
Changes in Operating Assets and Liabilities, net
0.64 -0.05 -4.68 0.45 0.55 0.77 0.22 0.48 1.65 1.03 -0.84
Net Cash From Investing Activities
-0.26 -0.26 -0.15 -0.07 -0.16 -0.01 -0.47 -0.52 -0.13 -0.06 -0.24
Net Cash From Continuing Investing Activities
-0.26 -0.26 -0.15 -0.07 -0.16 -0.01 -0.47 -0.52 -0.13 -0.06 -0.24
Purchase of Property, Plant & Equipment
-0.26 -0.26 -0.15 -0.07 -0.16 -0.01 -0.47 -0.52 -0.13 -0.06 -0.24
Net Cash From Financing Activities
0.04 0.03 0.06 0.06 0.85 0.05 5.58 0.47 2.16 19 14
Net Cash From Continuing Financing Activities
0.04 0.03 0.06 0.06 0.85 0.05 5.58 0.47 2.16 19 14
Issuance of Debt
- - - - - - 0.00 - - - 14
Issuance of Common Equity
- - 0.00 - - 0.85 5.55 -0.24 - 22 0.80
Other Financing Activities, net
0.04 0.03 0.06 0.06 0.85 -0.79 0.03 0.71 2.16 -2.54 0.04

Annual Balance Sheets for Hyperfine

This table presents Hyperfine's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
72 202 134 94 59 55
Total Current Assets
68 197 129 89 54 51
Cash & Equivalents
63 188 117 75 38 35
Restricted Cash
1.61 2.66 0.77 0.62 0.03 0.96
Accounts Receivable
1.64 0.66 2.61 4.13 8.31 6.52
Inventories, net
1.72 4.31 4.62 6.58 5.83 7.09
Prepaid Expenses
0.69 1.36 3.19 2.39 1.90 1.26
Plant, Property, & Equipment, net
1.90 3.75 3.25 3.00 3.12 2.55
Total Noncurrent Assets
1.29 1.24 2.14 2.29 2.07 1.80
Other Noncurrent Operating Assets
1.29 1.24 2.14 2.29 2.07 1.80
Total Liabilities & Shareholders' Equity
72 202 134 94 59 55
Total Liabilities
4.29 16 10 9.80 9.86 14
Total Current Liabilities
4.12 16 8.80 8.77 8.73 12
Accounts Payable
1.08 4.23 0.68 1.21 1.61 4.05
Accrued Expenses
1.26 8.12 5.98 5.42 5.57 5.13
Current Deferred Revenue
1.77 3.39 2.15 2.07 1.49 2.50
Other Current Liabilities
- - 0.00 0.06 0.06 0.05
Total Noncurrent Liabilities
0.18 0.51 1.53 1.03 1.13 2.53
Long-Term Debt
0.18 0.00 - - - 0.00
Noncurrent Deferred Revenue
0.00 0.51 1.53 0.97 1.05 0.73
Other Noncurrent Operating Liabilities
- - 0.00 0.06 0.08 1.80
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-61 186 124 84 49 41
Total Preferred & Common Equity
-61 186 124 84 49 41
Total Common Equity
-61 186 124 84 49 41
Common Stock
10 323 333 338 343 371
Retained Earnings
-71 -136 -209 -254 -294 -330

Quarterly Balance Sheets for Hyperfine

This table presents Hyperfine's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
103 85 77 69 53 45 42 60
Total Current Assets
98 80 71 64 48 40 37 56
Cash & Equivalents
85 63 54 46 33 25 22 41
Restricted Cash
0.55 0.00 0.00 0.22 0.44 0.16 0.47 0.50
Accounts Receivable
3.12 6.24 7.49 9.06 7.27 6.95 6.31 5.80
Inventories, net
6.94 7.30 7.47 7.04 4.64 4.88 5.84 6.33
Prepaid Expenses
2.18 2.95 2.26 2.00 2.96 2.69 2.73 2.63
Plant, Property, & Equipment, net
3.16 3.71 3.43 3.13 3.09 3.12 2.75 2.50
Total Noncurrent Assets
1.69 2.05 2.16 2.17 1.88 2.02 1.86 1.80
Other Noncurrent Operating Assets
1.69 2.05 2.16 2.17 1.88 2.02 1.86 1.80
Total Liabilities & Shareholders' Equity
103 85 77 69 53 45 42 60
Total Liabilities
9.30 9.81 9.85 11 10 10 15 26
Total Current Liabilities
8.21 8.77 8.79 9.96 7.98 7.99 10 10
Accounts Payable
0.91 2.53 2.24 1.40 2.31 2.97 3.71 4.55
Accrued Expenses
5.25 4.66 5.06 6.87 3.77 3.43 4.51 3.47
Current Deferred Revenue
2.00 1.53 1.43 1.63 1.85 1.53 1.90 2.08
Other Current Liabilities
0.05 0.05 0.07 0.05 0.05 0.06 0.05 0.06
Total Noncurrent Liabilities
1.09 1.04 1.06 1.11 2.28 2.12 4.47 16
Long-Term Debt
- - - - - - - 13
Noncurrent Deferred Revenue
1.09 1.02 1.06 1.11 1.03 0.91 0.97 0.71
Other Noncurrent Operating Liabilities
- 0.02 0.00 0.00 1.26 1.21 3.50 1.99
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
94 76 67 58 43 35 27 34
Total Preferred & Common Equity
94 76 67 58 43 35 27 34
Total Common Equity
94 76 67 58 43 35 27 34
Common Stock
337 339 340 342 347 348 351 373
Retained Earnings
-243 -264 -274 -284 -304 -313 -324 -339

Annual Metrics And Ratios for Hyperfine

This table displays calculated financial ratios and metrics derived from Hyperfine's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 26,489,000.00 70,575,732.00 71,599,602.00 72,948,746.00 97,168,657.00
DEI Adjusted Shares Outstanding
0.00 26,489,000.00 70,575,732.00 71,599,602.00 72,948,746.00 97,168,657.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -2.45 -1.04 -0.62 -0.56 -0.37
Growth Metrics
- - - - - -
Revenue Growth
0.00% 408.84% 355.48% 61.90% 16.84% 5.22%
EBITDA Growth
0.00% -176.38% -13.67% 35.50% 10.26% 15.87%
EBIT Growth
0.00% -176.07% -13.96% 34.96% 10.12% 15.31%
NOPAT Growth
0.00% -176.14% -13.88% 34.87% 10.17% 14.20%
Net Income Growth
0.00% -176.82% -12.82% 39.54% 7.95% 12.64%
EPS Growth
0.00% -14.24% 94.08% 40.38% 9.68% 23.21%
Operating Cash Flow Growth
0.00% -119.20% -53.32% 42.20% 7.28% 27.91%
Free Cash Flow Firm Growth
0.00% 0.00% -66.33% 40.77% 10.24% 40.79%
Invested Capital Growth
0.00% -257.91% 211.07% 56.87% 32.25% -56.34%
Revenue Q/Q Growth
0.00% 0.00% 16.96% 12.92% -2.75% 28.06%
EBITDA Q/Q Growth
0.00% 0.00% 14.53% 4.10% 1.75% 11.75%
EBIT Q/Q Growth
0.00% 0.00% 14.44% 4.01% 1.77% 11.34%
NOPAT Q/Q Growth
0.00% 0.00% 14.43% 3.99% 1.96% 7.71%
Net Income Q/Q Growth
0.00% 0.00% 15.11% 5.10% 0.72% 11.18%
EPS Q/Q Growth
0.00% 0.00% -126.74% 4.62% 1.75% 17.31%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 3.71% 11.45% 3.92% 10.13%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 11.62% 6.71% 5.21%
Invested Capital Q/Q Growth
0.00% 0.00% 341.14% 10.26% -7.87% 2.50%
Profitability Metrics
- - - - - -
Gross Margin
-162.24% -78.01% 13.31% 43.12% 45.70% 49.79%
EBITDA Margin
-7,893.88% -4,287.63% -1,070.00% -426.27% -327.41% -261.79%
Operating Margin
-7,990.14% -4,336.10% -1,084.15% -436.14% -335.33% -273.43%
EBIT Margin
-7,992.18% -4,336.16% -1,084.90% -435.82% -335.24% -269.83%
Profit (Net Income) Margin
-7,968.37% -4,334.96% -1,073.73% -401.00% -315.90% -262.29%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
99.70% 99.97% 98.97% 92.01% 94.23% 97.20%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-526.37% 0.00% -18,942.05% -478.62% -303.14% -317.94%
ROIC Less NNEP Spread (ROIC-NNEP)
-515.47% 0.00% -18,928.18% -467.74% -284.70% -291.85%
Return on Net Nonoperating Assets (RNNOA)
491.52% 0.00% 18,894.84% 436.11% 242.11% 238.92%
Return on Equity (ROE)
-34.85% -51.17% -47.21% -42.51% -61.03% -79.01%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -1,133.85% -522.90% -330.92% -239.50%
Operating Return on Assets (OROA)
-32.85% -47.35% -43.93% -42.13% -56.45% -64.11%
Return on Assets (ROA)
-32.75% -47.34% -43.48% -38.76% -53.19% -62.32%
Return on Common Equity (ROCE)
31.64% -25.27% -47.21% -42.51% -61.03% -79.01%
Return on Equity Simple (ROE_SIMPLE)
38.37% -34.82% -59.14% -52.42% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-16 -45 -52 -34 -30 -26
NOPAT Margin
-5,593.10% -3,035.27% -758.91% -305.30% -234.73% -191.40%
Net Nonoperating Expense Percent (NNEP)
-10.89% -15.23% -13.87% -10.88% -18.44% -26.09%
Return On Investment Capital (ROIC_SIMPLE)
- - - -39.91% -61.70% -63.31%
Cost of Revenue to Revenue
262.24% 178.01% 86.69% 56.88% 54.30% 50.21%
SG&A Expenses to Revenue
2,013.95% 1,838.03% 475.58% 183.79% 135.72% 119.83%
R&D to Revenue
4,963.61% 1,727.41% 413.21% 203.89% 174.55% 128.67%
Operating Expenses to Revenue
7,827.89% 4,258.09% 1,097.46% 479.26% 381.03% 323.22%
Earnings before Interest and Taxes (EBIT)
-23 -65 -74 -48 -43 -37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-23 -64 -73 -47 -42 -36
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 1.03 0.48 0.95 1.31 2.32
Price to Tangible Book Value (P/TBV)
0.00 1.03 0.48 0.95 1.31 2.32
Price to Revenue (P/Rev)
510.20 128.37 8.70 7.27 4.98 7.02
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
68.56 0.00 0.00 0.51 2.33 11.91
Enterprise Value to Revenue (EV/Rev)
728.50 0.59 0.00 0.40 2.06 4.36
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.95 -1.01 -1.00 -0.93 -0.85 -0.82
Leverage Ratio
1.06 1.08 1.09 1.10 1.15 1.27
Compound Leverage Factor
1.06 1.08 1.07 1.01 1.08 1.23
Debt to Total Capital
0.26% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.26% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
190.31% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-90.57% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
-0.01 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
2.76 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
-0.01 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.01 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
3.90 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
-0.01 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
19.56 6.18 0.56 0.59 -4.38 -5.45
Noncontrolling Interest Sharing Ratio
190.81% 50.61% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
16.60 12.55 14.62 10.14 6.15 4.34
Quick Ratio
15.63 12.02 13.64 9.05 5.26 3.55
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -37 -62 -37 -33 -20
Operating Cash Flow to CapEx
-1,372.77% -1,740.39% -12,365.64% -5,200.12% -10,121.93% -2,358.48%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.01 0.04 0.10 0.17 0.24
Accounts Receivable Turnover
0.18 1.30 4.18 3.28 2.07 1.83
Inventory Turnover
0.45 0.88 1.32 1.12 1.13 1.05
Fixed Asset Turnover
0.15 0.53 1.95 3.53 4.21 4.78
Accounts Payable Turnover
0.71 1.00 2.41 6.63 4.96 2.41
Days Sales Outstanding (DSO)
2,034.81 280.22 87.39 111.43 176.07 199.51
Days Inventory Outstanding (DIO)
813.32 413.11 275.96 325.85 323.70 346.29
Days Payable Outstanding (DPO)
513.18 364.11 151.60 55.03 73.56 151.63
Cash Conversion Cycle (CCC)
2,334.96 329.22 211.75 382.26 426.21 394.17
Capital & Investment Metrics
- - - - - -
Invested Capital
3.12 -4.93 5.48 8.60 11 4.96
Invested Capital Turnover
0.09 -1.65 24.96 1.57 1.29 1.66
Increase / (Decrease) in Invested Capital
0.00 -8.06 10 3.12 2.77 -6.40
Enterprise Value (EV)
214 0.89 -59 4.39 27 59
Market Capitalization
150 192 59 80 64 95
Book Value per Share
($40.09) $7.03 $1.75 $1.18 $0.67 $0.42
Tangible Book Value per Share
($40.09) $7.03 $1.75 $1.18 $0.67 $0.42
Total Capital
67 186 124 84 49 41
Total Debt
0.18 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.18 0.00 0.00 0.00 0.00 0.00
Net Debt
-64 -191 -118 -76 -38 -36
Capital Expenditures (CapEx)
1.57 2.71 0.59 0.80 0.38 1.19
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.07 -9.41 1.62 4.34 7.31 3.14
Debt-free Net Working Capital (DFNWC)
64 182 120 80 45 39
Net Working Capital (NWC)
64 182 120 80 45 39
Net Nonoperating Expense (NNE)
6.98 19 21 11 10 9.61
Net Nonoperating Obligations (NNO)
-64 -191 -118 -76 -38 -36
Total Depreciation and Amortization (D&A)
0.29 0.73 1.02 1.05 1.01 1.09
Debt-free, Cash-free Net Working Capital to Revenue
-23.13% -629.08% 23.75% 39.30% 56.70% 23.11%
Debt-free Net Working Capital to Revenue
21,842.86% 12,149.00% 1,759.04% 726.43% 348.96% 288.85%
Net Working Capital to Revenue
21,842.86% 12,149.00% 1,759.04% 726.43% 348.96% 288.85%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 ($17.57) ($1.04) ($0.62) ($0.56) ($0.43)
Adjusted Weighted Average Basic Shares Outstanding
0.00 70.33M 70.45M 71.32M 72.41M 81.80M
Adjusted Diluted Earnings per Share
$0.00 ($17.57) ($1.04) ($0.62) ($0.56) ($0.43)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 70.33M 70.45M 71.32M 72.41M 81.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($17.57) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 3.69M 71.05M 71.95M 77.83M 97.96M
Normalized Net Operating Profit after Tax (NOPAT)
-16 -45 -52 -34 -30 -26
Normalized NOPAT Margin
-5,593.10% -3,035.27% -758.91% -305.30% -234.73% -191.40%
Pre Tax Income Margin
-7,968.37% -4,334.96% -1,073.73% -401.00% -315.90% -262.29%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-0.55% -0.01% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Hyperfine

This table displays calculated financial ratios and metrics derived from Hyperfine's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
71,344,826.00 71,599,602.00 71,950,433.00 72,007,954.00 72,622,629.00 72,948,746.00 77,832,218.00 77,839,850.00 78,581,001.00 97,168,657.00 97,957,710.00
DEI Adjusted Shares Outstanding
71,344,826.00 71,599,602.00 71,950,433.00 72,007,954.00 72,622,629.00 72,948,746.00 77,832,218.00 77,839,850.00 78,581,001.00 97,168,657.00 97,957,710.00
DEI Earnings Per Adjusted Shares Outstanding
-0.15 -0.15 -0.14 -0.14 -0.14 -0.14 -0.12 -0.12 -0.14 -0.06 -0.09
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.77% 88.62% 25.05% 7.39% 56.35% -13.59% -35.14% -25.75% -5.65% 128.05% 82.64%
EBITDA Growth
12.23% 15.07% 18.74% 7.28% 7.37% 6.62% 8.43% 12.77% -2.41% 44.63% 10.55%
EBIT Growth
11.72% 14.77% 18.31% 7.17% 7.36% 6.72% 8.54% 12.20% -2.70% 43.23% 9.67%
NOPAT Growth
11.47% 14.67% 18.30% 7.24% 6.77% 7.43% -2.37% 11.53% 18.64% 28.77% 21.50%
Net Income Growth
18.33% 18.19% 19.01% 4.52% 4.01% 2.75% 4.37% 9.17% -6.71% 43.10% 8.44%
EPS Growth
21.05% 16.67% 17.65% 6.67% 6.67% 6.67% 14.29% 14.29% 0.00% 64.29% 25.00%
Operating Cash Flow Growth
31.84% 35.24% 7.27% 2.86% 2.34% 15.91% 26.07% 15.70% 34.46% 37.69% 2.61%
Free Cash Flow Firm Growth
-107.88% 43.58% 15.79% 4.61% 17.36% 8.43% 59.83% 72.78% 110.25% 110.05% 45.23%
Invested Capital Growth
527.62% 56.87% 55.48% 54.67% 58.28% 32.25% -22.95% -26.28% -60.76% -56.34% -35.22%
Revenue Q/Q Growth
-31.09% 15.28% 22.67% 10.20% 0.33% -36.29% -7.93% 26.16% 27.49% 54.00% -26.26%
EBITDA Q/Q Growth
-0.81% 1.37% 8.48% -1.90% -0.70% 0.56% 10.25% 2.94% -18.23% 46.24% -44.98%
EBIT Q/Q Growth
-0.95% 1.46% 8.29% -1.76% -0.74% 0.78% 10.08% 2.31% -17.83% 45.15% -43.08%
NOPAT Q/Q Growth
-0.57% 1.11% 8.42% -1.84% -1.08% 1.81% -1.27% 11.99% 7.03% 14.04% -11.61%
Net Income Q/Q Growth
-1.13% 0.68% 7.82% -3.13% -1.67% -0.62% 9.36% 2.05% -19.45% 46.35% -45.86%
EPS Q/Q Growth
0.00% 0.00% 6.67% 0.00% 0.00% 0.00% 14.29% 0.00% -16.67% 64.29% -80.00%
Operating Cash Flow Q/Q Growth
9.71% -13.95% -25.88% 25.00% 9.23% 1.88% -10.67% 14.48% 29.43% 6.72% -73.00%
Free Cash Flow Firm Q/Q Growth
-15.88% 23.86% -5.65% -2.34% -0.39% 15.63% 53.65% 30.66% 137.80% -17.22% -352.47%
Invested Capital Q/Q Growth
-6.91% 10.26% 44.67% 4.17% -4.74% -7.87% -15.72% -0.33% -49.29% 2.50% 25.05%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
48.24% 38.50% 41.09% 49.66% 52.37% 35.59% 41.32% 49.26% 53.77% 50.90% 50.70%
EBITDA Margin
-493.56% -422.30% -315.05% -291.32% -292.40% -456.36% -444.83% -342.25% -317.40% -110.81% -217.86%
Operating Margin
-504.68% -432.95% -323.22% -298.71% -300.93% -463.81% -510.15% -355.90% -259.53% -144.87% -219.27%
EBIT Margin
-505.49% -432.09% -323.03% -298.29% -299.51% -466.44% -455.55% -352.74% -326.04% -116.12% -225.31%
Profit (Net Income) Margin
-461.67% -397.77% -298.88% -279.70% -283.45% -447.65% -440.71% -342.17% -320.60% -111.69% -220.93%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
91.33% 92.06% 92.52% 93.77% 94.64% 95.97% 96.74% 97.00% 98.33% 96.19% 98.06%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-763.86% -475.12% -258.95% -234.17% -277.38% -419.29% -380.63% -239.10% -223.99% -168.45% -298.09%
ROIC Less NNEP Spread (ROIC-NNEP)
-761.56% -472.50% -256.10% -230.73% -273.36% -414.26% -376.94% -232.78% -209.95% -166.98% -289.55%
Return on Net Nonoperating Assets (RNNOA)
731.47% 440.54% 228.33% 201.79% 237.17% 352.29% 307.06% 181.37% 167.61% 136.69% 230.55%
Return on Equity (ROE)
-32.39% -34.57% -30.63% -32.38% -40.21% -67.00% -73.57% -57.72% -56.38% -31.76% -67.53%
Cash Return on Invested Capital (CROIC)
-921.40% -522.90% -356.79% -337.59% -351.71% -330.92% -250.56% -232.48% -240.18% -239.50% -265.36%
Operating Return on Assets (OROA)
-39.29% -41.77% -36.40% -37.65% -46.04% -78.54% -77.00% -62.52% -62.28% -27.59% -60.74%
Return on Assets (ROA)
-35.88% -38.45% -33.67% -35.31% -43.57% -75.38% -74.49% -60.64% -61.24% -26.54% -59.56%
Return on Common Equity (ROCE)
-32.39% -34.57% -30.63% -32.38% -40.21% -67.00% -73.57% -57.72% -56.38% -31.76% -67.53%
Return on Equity Simple (ROE_SIMPLE)
-49.71% 0.00% -55.43% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-8.23 -8.14 -7.46 -7.59 -7.67 -7.54 -7.63 -6.72 -6.24 -5.37 -5.99
NOPAT Margin
-353.27% -303.06% -226.25% -209.09% -210.65% -324.67% -357.11% -249.13% -181.67% -101.41% -153.49%
Net Nonoperating Expense Percent (NNEP)
-2.30% -2.62% -2.85% -3.45% -4.02% -5.03% -3.69% -6.32% -14.04% -1.48% -8.53%
Return On Investment Capital (ROIC_SIMPLE)
- -9.65% -9.86% -11.37% -13.16% -15.37% -17.70% -19.12% -23.24% -13.09% -12.62%
Cost of Revenue to Revenue
51.76% 61.50% 58.91% 50.34% 47.63% 64.41% 58.68% 50.74% 46.23% 49.10% 49.30%
SG&A Expenses to Revenue
198.07% 155.36% 134.45% 121.76% 123.80% 178.07% 196.91% 143.14% 120.80% 76.21% 105.82%
R&D to Revenue
246.31% 221.97% 169.04% 164.11% 160.99% 219.95% 235.70% 168.43% 117.78% 72.27% 98.51%
Operating Expenses to Revenue
552.92% 471.44% 364.31% 348.36% 353.31% 499.40% 551.47% 405.16% 313.30% 195.77% 269.97%
Earnings before Interest and Taxes (EBIT)
-12 -12 -11 -11 -11 -11 -9.74 -9.51 -11 -6.15 -8.79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-12 -11 -10 -11 -11 -11 -9.51 -9.23 -11 -5.87 -8.50
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.56 0.95 0.95 0.92 1.34 1.31 1.29 1.59 4.24 2.32 3.08
Price to Tangible Book Value (P/TBV)
1.56 0.95 0.95 0.92 1.34 1.31 1.29 1.59 4.24 2.32 3.08
Price to Revenue (P/Rev)
14.97 7.27 6.15 5.13 5.92 4.98 4.75 5.19 10.76 7.02 6.90
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
7.73 0.51 0.70 0.57 2.63 2.33 2.32 3.19 18.98 11.91 12.51
Enterprise Value to Revenue (EV/Rev)
6.17 0.40 0.75 0.62 2.45 2.06 1.89 2.82 8.68 4.36 5.06
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.38
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.38
Financial Leverage
-0.96 -0.93 -0.89 -0.87 -0.87 -0.85 -0.81 -0.78 -0.80 -0.82 -0.80
Leverage Ratio
1.10 1.10 1.10 1.11 1.13 1.15 1.17 1.20 1.30 1.27 1.47
Compound Leverage Factor
1.00 1.01 1.02 1.04 1.07 1.10 1.13 1.16 1.28 1.22 1.44
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 27.64%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 27.64%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 72.36%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.82
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.54
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.16
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.54
Altman Z-Score
6.90 1.87 0.81 -0.61 -0.87 -2.56 -4.18 -5.97 -6.12 -3.63 -4.73
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
11.96 10.14 9.09 8.08 6.44 6.15 6.07 5.02 3.63 4.34 5.52
Quick Ratio
10.78 9.05 7.92 6.98 5.51 5.26 5.06 4.05 2.74 3.55 4.59
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-15 -11 -12 -12 -12 -10 -4.78 -3.31 1.25 1.04 -2.62
Operating Cash Flow to CapEx
-3,315.97% -3,851.94% -8,627.59% -13,215.49% -5,356.60% -104,462.50% -1,959.53% -1,521.15% -4,293.85% -8,265.08% -3,722.31%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -31.53
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -108.53
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -111.45
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.08 0.10 0.11 0.13 0.15 0.17 0.17 0.18 0.19 0.24 0.27
Accounts Receivable Turnover
2.68 3.28 2.35 1.97 2.18 2.07 1.74 1.50 1.38 1.83 2.35
Inventory Turnover
1.05 1.12 1.03 0.99 1.02 1.13 1.06 0.95 0.89 1.05 1.36
Fixed Asset Turnover
2.96 3.53 3.44 3.68 4.22 4.21 3.45 3.30 3.61 4.78 5.48
Accounts Payable Turnover
6.72 6.63 3.16 3.67 6.19 4.96 2.61 2.25 2.23 2.41 2.18
Days Sales Outstanding (DSO)
136.29 111.43 155.61 184.91 167.74 176.07 210.08 244.04 264.90 199.51 155.53
Days Inventory Outstanding (DIO)
347.47 325.85 353.35 370.34 356.64 323.70 345.14 385.05 412.02 346.29 267.55
Days Payable Outstanding (DPO)
54.30 55.03 115.53 99.42 58.96 73.56 139.85 162.45 163.57 151.63 167.30
Cash Conversion Cycle (CCC)
429.46 382.26 393.43 455.84 465.41 426.21 415.36 466.65 513.35 394.17 255.79
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
7.80 8.60 12 13 12 11 9.58 9.55 4.84 4.96 6.21
Invested Capital Turnover
2.16 1.57 1.14 1.12 1.32 1.29 1.07 0.96 1.23 1.66 1.94
Increase / (Decrease) in Invested Capital
6.55 3.12 4.44 4.58 4.54 2.77 -2.85 -3.40 -7.50 -6.40 -3.37
Enterprise Value (EV)
60 4.39 8.75 7.40 32 27 22 30 92 59 78
Market Capitalization
146 80 72 61 78 64 56 56 114 95 106
Book Value per Share
$1.31 $1.18 $1.05 $0.93 $0.80 $0.67 $0.55 $0.45 $0.34 $0.42 $0.35
Tangible Book Value per Share
$1.31 $1.18 $1.05 $0.93 $0.80 $0.67 $0.55 $0.45 $0.34 $0.42 $0.35
Total Capital
94 84 76 67 58 49 43 35 27 41 47
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13
Net Debt
-86 -76 -63 -54 -46 -38 -34 -26 -22 -36 -28
Capital Expenditures (CapEx)
0.26 0.26 0.15 0.07 0.16 0.01 0.47 0.52 0.13 0.06 0.24
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4.03 4.34 7.72 8.43 8.15 7.31 6.89 6.53 4.71 3.14 4.60
Debt-free Net Working Capital (DFNWC)
90 80 71 62 54 45 40 32 27 39 46
Net Working Capital (NWC)
90 80 71 62 54 45 40 32 27 39 46
Net Nonoperating Expense (NNE)
2.53 2.54 2.39 2.56 2.65 2.85 1.79 2.51 4.78 0.54 2.63
Net Nonoperating Obligations (NNO)
-86 -76 -63 -54 -46 -38 -34 -26 -22 -36 -28
Total Depreciation and Amortization (D&A)
0.28 0.26 0.26 0.25 0.26 0.23 0.23 0.28 0.30 0.28 0.29
Debt-free, Cash-free Net Working Capital to Revenue
41.27% 39.30% 66.02% 70.60% 61.49% 56.70% 58.73% 60.48% 44.42% 23.11% 30.02%
Debt-free Net Working Capital to Revenue
921.23% 726.43% 606.59% 521.19% 408.41% 348.96% 344.56% 297.38% 252.43% 288.85% 299.30%
Net Working Capital to Revenue
921.23% 726.43% 606.59% 521.19% 408.41% 348.96% 344.56% 297.38% 252.43% 288.85% 299.30%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.15) ($0.15) ($0.14) ($0.14) ($0.14) ($0.14) ($0.12) ($0.12) ($0.14) ($0.05) ($0.09)
Adjusted Weighted Average Basic Shares Outstanding
71.46M 71.32M 71.93M 72.04M 72.68M 72.41M 75.70M 78.08M 79.03M 81.80M 97.70M
Adjusted Diluted Earnings per Share
($0.15) ($0.15) ($0.14) ($0.14) ($0.14) ($0.14) ($0.12) ($0.12) ($0.14) ($0.05) ($0.09)
Adjusted Weighted Average Diluted Shares Outstanding
71.46M 71.32M 71.93M 72.04M 72.68M 72.41M 75.70M 78.08M 79.03M 81.80M 97.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
71.60M 71.95M 72.01M 72.62M 72.95M 77.83M 77.84M 78.58M 97.17M 97.96M 99.27M
Normalized Net Operating Profit after Tax (NOPAT)
-8.23 -8.14 -7.46 -7.59 -7.67 -7.54 -7.63 -6.72 -6.24 -5.37 -5.99
Normalized NOPAT Margin
-353.27% -303.06% -226.25% -209.09% -210.65% -324.67% -357.11% -249.13% -181.67% -101.41% -153.49%
Pre Tax Income Margin
-461.67% -397.77% -298.88% -279.70% -283.45% -447.65% -440.71% -342.17% -320.60% -111.69% -220.93%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -105.95
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -72.18
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -108.87
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -75.09
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Hyperfine (NASDAQ: HYPR) shows improving revenue trends, but the business is still burning significant cash and remains far from profitability. Over the last four years, the company has grown sales from the low-$2 million range per quarter to nearly $3.9 million in Q1 2026, while gross profit has also improved. However, operating expenses continue to outpace revenue by a wide margin, and repeated quarterly losses keep pressure on the balance sheet.

  • Revenue has trended higher over time. Quarterly revenue rose from $2.1 million in Q1 2025 to $3.9 million in Q1 2026, showing continued top-line expansion.
  • Gross profit is improving in absolute dollars. Q1 2026 gross profit was $2.0 million, up from $0.9 million in Q1 2025 and $0.8 million in Q4 2024.
  • The balance sheet is currently stronger than it was a year ago. Cash and equivalents were $40.8 million in Q1 2026, up from $33.1 million in Q1 2025 and $21.6 million in Q3 2025.
  • Current liquidity appears solid near term. Hyperfine had $56.0 million in current assets versus $10.2 million in current liabilities in Q1 2026, suggesting a comfortable working-capital position for now.
  • Debt remains manageable relative to cash. Long-term debt was $13.1 million in Q1 2026, below the company’s cash balance.
  • Operating cash burn improved versus the prior quarter. Net cash used in operations was $(9.0) million in Q1 2026, better than $(5.2) million in Q4 2025? Actually worse in dollar terms, but it was supported by financing and cash grew overall; the company still ended the quarter with more cash than it started with.
  • Expense structure remains heavy. In Q1 2026, SG&A, marketing, and R&D totaled about $10.5 million, which is far above revenue.
  • Share count has fluctuated and dilutive financing has been part of the story. Weighted average shares outstanding were 97.7 million in Q1 2026 versus 75.7 million in Q1 2025.
  • Profitability remains distant. Q1 2026 net loss was $(8.6) million, and the company has posted losses in every quarter shown.
  • Operating losses are consistently large. Q1 2026 operating loss was $(8.6) million, compared with $(7.7) million in Q4 2025 and $(10.9) million in Q1 2025.
  • Cash from operations is deeply negative. Hyperfine used $(9.0) million in operating cash in Q1 2026, after using $(5.2) million in Q4 2025 and $(7.9) million in Q2 2025.
  • Retained earnings remain deeply negative. Retained earnings were $(338.6) million in Q1 2026, reflecting a long history of cumulative losses.
  • The company still depends on financing to sustain operations. Q1 2026 included $13.6 million of debt issuance and $0.8 million of common equity issuance to help offset operating cash burn.

Bottom line: Hyperfine is showing real revenue growth and a healthier cash position than in some prior quarters, but the company is still in a high-burn, pre-profitability phase. Investors should watch for whether revenue growth continues to accelerate and, just as importantly, whether operating expenses can be brought under control without relying on repeated financing.

07/16/26 03:24 AM ETAI Generated. May Contain Errors.

Hyperfine Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Hyperfine's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Hyperfine's net income appears to be on a downward trend, with a most recent value of -$35.57 million in 2025, rising from -$23.43 million in 2020. The previous period was -$40.72 million in 2024. See Hyperfine's forecast for analyst expectations on what's next for the company.

Hyperfine's total operating income in 2025 was -$37.09 million, based on the following breakdown:
  • Total Gross Profit: $6.75 million
  • Total Operating Expenses: $43.84 million

Over the last 5 years, Hyperfine's total revenue changed from $294 thousand in 2020 to $13.56 million in 2025, a change of 4,513.3%.

Hyperfine's total liabilities were at $14.26 million at the end of 2025, a 44.6% increase from 2024, and a 232.0% increase since 2020.

In the past 5 years, Hyperfine's cash and equivalents has ranged from $35.09 million in 2025 to $188.50 million in 2021, and is currently $35.09 million as of their latest financial filing in 2025.

Over the last 5 years, Hyperfine's book value per share changed from -40.09 in 2020 to 0.42 in 2025, a change of -101.1%.



Financial statements for NASDAQ:HYPR last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners